Castle Biosciences (CSTL) Treasury Shares (2018 - 2019)

Castle Biosciences has reported Treasury Shares for 9 years, with the latest figure at $4.1 million in Q2 2026.

• Quarterly Treasury Shares changed N/A year-over-year to $4.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.1 million (changed N/A YoY) and the FY2025 annual result came in at $3.4 million, up 6.24% from the prior year.
• Treasury Shares improved to $4.1 million in Q2 2026 per CSTL's latest filing, from $4.0 million in the prior quarter.
• Over five years, Treasury Shares peaked at $4.1 million in Q2 2026 and troughed at $2.8 million in Q4 2023.
• A 5-year average of $3.6 million and a median of $3.5 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares jumped 231.18% in 2022, then retreated 19.35% in 2023.
• Over 5 years, Treasury Shares stood at $3.5 million in 2022, then fell by 19.35% to $2.8 million in 2023, then climbed by 13.94% to $3.2 million in 2024, then grew by 6.24% to $3.4 million in 2025, then increased by 22.15% to $4.1 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $4.1 million, $4.0 million, and $3.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.